Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue

International Journal of Molecular Medicine

Volumn 37, Issue 1, 2016, Pages 115-125

  Heo, June Seok ^a   Choi, Youjeong ^a   Kim, Han Soo ^c   Kim, Hyun Ok ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Catholic Kwandong University   (South Korea)

Author keywords

Distal less homeobox 5; Mesenchymal stem cells; Multipotency

Indexed keywords

5' NUCLEOTIDASE; B4GALNT1 PROTEIN; BETA1 INTEGRIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CD14 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HERMES ANTIGEN; INHIBIN B; INTERLEUKIN 10; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; OSTEOGENIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THY 1 ANTIGEN; TRANSCRIPTION FACTOR DLX5; TRANSCRIPTION FACTOR LIN28; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR REX1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; DLX5 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTOME;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CARTILAGE CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL PROLIFERATION; CELL RENEWAL; CELL STRUCTURE; CHONDROGENESIS; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPHENOTYPING; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MARKER GENE; OSTEOBLAST; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; TISSUE ENGINEERING; UMBILICAL CORD BLOOD; YOUNG ADULT; BONE DEVELOPMENT; BONE MARROW CELL; CELL CULTURE; CYTOLOGY; FETUS BLOOD; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PREGNANCY;

ADIPOSE TISSUE; ADULT; BONE MARROW CELLS; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FETAL BLOOD; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; PLACENTA; PREGNANCY; TRANSCRIPTION FACTORS; TRANSCRIPTOME; YOUNG ADULT;

EID: 84948735569     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2015.2413     Document Type: Article

References (50)

1. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, et al: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49, 2002.
2. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, Boggs SS, Greenberger JS and Goff JP: Bone marrow as a potential source of hepatic oval cells. Science 284: 1168-1170, 1999.
3. Prockop DJ, Gregory CA and Spees JL: One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci USA 100 (Suppl 1): 11917-11923, 2003.
4. Schwartz RE, Reyes M, Koodie L, Jiang Y, Blackstad M, Lund T, Lenvik T, Johnson S, Hu WS and Verfaillie CM: Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 109: 1291-1302, 2002.
5. Ryan JM, Barry FP, Murphy JM and Mahon BP: Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2: 8, 2005.
6. Mastri M, Lin H and Lee T: Enhancing the efficacy of mesenchymal stem cell therapy. World J Stem Cells 6: 82-93, 2014.
7. Sharma RR, Pollock K, Hubel A and McKenna D: Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion 54: 1418-1437, 2014.
8. Friedenstein AJ, Piatetzky-Shapiro II and Petrakova KV: Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 16: 381-390, 1966.
9. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147, 1999.
10. Bajpai VK, Mistriotis P and Andreadis ST: Clonal multipotency and effect of long-term in vitro expansion on differentiation potential of human hair follicle derived mesenchymal stem cells. Stem Cell Res (Amst) 8: 74-84, 2012.
11. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I and Fisk NM: Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98: 2396-2402, 2001.
12. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE and Kanhai HH: Isolation of mesenchymal stem cells of fetral or maternal origin from human placenta. Stem Cells 22: 1338-1345, 2004.
13. Ryu KH, Cho KA, Park HS, Kim JY, Woo SY, Jo I, Choi YH, Park YM, Jung SC, Chung SM, et al: Tonsil-derived mesenchymal stromal cells: Evaluation of biologic, immunologic and genetic factors for successful banking. Cytotherapy 14: 1193-1202, 2012.
14. Toma JG, Akhavan M, Fernandes KJ, Barnabé-Heider F, Sadikot A, Kaplan DR and Miller FD: Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 3: 778-784, 2001.
15. Kern S, Eichler H, Stoeve J, Klüter H and Bieback K: Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301, 2006.
16. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, Blake J, Schwager C, Eckstein V, Ansorge W and Ho AD: Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33: 1402-1416, 2005.
17. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ and Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317, 2006.
18. Sohn HS, Heo JS, Kim HS, Choi Y and Kim HO: Duration of in vitro storage affects the key stem cell features of human bone marrow-derived mesenchymal stromal cells for clinical transplantation. Cytotherapy 15: 460-466, 2013.
19. Choudhery MS, Khan M, Mahmood R, Mehmood A, Khan SN and Riazuddin S: Bone marrow derived mesenchymal stem cells from aged mice have reduced wound healing, angiogenesis, proliferation and anti-apoptosis capabilities. Cell Biol Int 36: 747-753, 2012.
20. Jääger K and Neuman T: Human dermal fibroblasts exhibit delayed adipogenic differentiation compared with mesenchymal stem cells. Stem Cells Dev 20: 1327-1336, 2011.
21. Ménard C and Tarte K: Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application. Stem Cell Res Ther 4: 64, 2013.
22. Bianco P, Riminucci M, Gronthos S and Robey PG: Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19: 180-192, 2001.
23. Kemp KC, Hows J and Donaldson C: Bone marrow-derived mesenchymal stem cells. Leuk Lymphoma 46: 1531-1544, 2005.
24. Bieback K, Kern S, Klüter H and Eichler H: Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22: 625-634, 2004.
25. Evangelista M, Soncini M and Parolini O: Placenta-derived stem cells: new hope for cell therapy? Cytotechnology 58: 33-42, 2008.
26. Ikegame Y, Yamashita K, Hayashi S, Mizuno H, Tawada M, You F, Yamada K, Tanaka Y, Egashira Y, Nakashima S, et al: Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 13: 675-685, 2011.
27. Sousa BR1, Parreira RC, Fonseca EA, Amaya MJ, Tonelli FM, Lacerda SM, Lalwani P, Santos AK, Gomes KN, Ulrich H, et al: Human adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applications. Cytometry A 85: 43-77, 2014.
28. Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, Benes V, Blake J, Pfister S, Eckstein V and Ho AD: Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 3: e2213, 2008.
29. Yoon DS, Kim YH, Jung HS, Paik S and Lee JW: Importance of Sox2 in maintenance of cell proliferation and multipotency of mesenchymal stem cells in low-density culture. Cell Prolif 44: 428-440, 2011.
30. Kishi M, Mizuseki K, Sasai N, Yamazaki H, Shiota K, Nakanishi S and Sasai Y: Requirement of Sox2-mediated signaling for differentiation of early Xenopus neuroectoderm. Development 127: 791-800, 2000.
31. Djouad F, Jackson WM, Bobick BE, Janjanin S, Song Y, Huang GT and Tuan RS: Activin A expression regulates multipotency of mesenchymal progenitor cells. Stem Cell Res Ther 1: 11, 2010.
32. Shi M, Liu ZW and Wang FS: Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol 164: 1-8, 2011.
33. Nasef A, Mathieu N, Chapel A, Frick J, François S, Mazurier C, Boutarfa A, Bouchet S, Gorin NC, Thierry D and Fouillard L: Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation 84: 231-237, 2007.
34. Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, Borg C, Saas P, Tiberghien P, Rouas-Freiss N, et al: Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells 26: 212-222, 2008.
35. Bunnell BA, Betancourt AM and Sullivan DE: New concepts on the immune modulation mediated by mesenchymal stem cells. Stem Cell Res Ther 1: 34, 2010.
36. Kim HO, Choi SM, Kim HS: Mesenchymal stem cell-derived secretome and microvesicles as a cell-free therapeutics for neurodegenerative disorders. Tissue Eng Reg Med 10: 93-101, 2013.
37. Grütz G: New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol 77: 3-15, 2005.
38. Marie JC, Letterio JJ, Gavin M and Rudensky AY: TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 201: 1061-1067, 2005.
39. Nasef A, Chapel A, Mazurier C, Bouchet S, Lopez M, Mathieu N, Sensebé L, Zhang Y, Gorin NC, Thierry D and Fouillard L: Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Expr 13: 217-226, 2007.
40. Martinez C, Hofmann TJ, Marino R, Dominici M and Horwitz EM: Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs. Blood 109: 4245-4248, 2007.
41. Harada S and Rodan GA: Control of osteoblast function and regulation of bone mass. Nature 423: 349-355, 2003.
42. Long JE, Garel S, Depew MJ, Tobet S and Rubenstein JL: DLX5 regulates development of peripheral and central components of the olfactory system. J Neurosci 23: 568-578, 2003.
43. Phinney DG, Kopen G, Righter W, Webster S, Tremain N and Prockop DJ: Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 75: 424-436, 1999.
44. Portalska KJ, Groen N, Krenning G, Georgi N, Mentink A, Harmsen MC, van Blitterswijk C and de Boer J: The effect of donor variation and senescence on endothelial differentiation of human mesenchymal stromal cells. Tissue Eng Part A 19: 2318-2329, 2013.
45. Ho AD, Wagner W and Franke W: Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy 10: 320-330, 2008.
46. Li Z, Zhang C, Weiner LP, Zhang Y and Zhong JF: Molecular characterization of heterogeneous mesenchymal stem cells with single-cell transcriptomes. Biotechnol Adv 31: 312-317, 2013.
47. Sivasubramaniyan K, Lehnen D, Ghazanfari R, Sobiesiak M, Harichandan A, Mortha E, Petkova N, Grimm S, Cerabona F, de Zwart P, et al: Phenotypic and functional heterogeneity of human bone marrow-and amnion-derived MSC subsets. Ann NY Acad Sci 1266: 94-106, 2012.
48. Noer A, Sørensen AL, Boquest AC and Collas P: Stable CpG hypomethylation of adipogenic promoters in freshly isolated, cultured, and differentiated mesenchymal stem cells from adipose tissue. Mol Biol Cell 17: 3543-3556, 2006.
49. Dominici M, Paolucci P, Conte P and Horwitz EM: Heterogeneity of multipotent mesenchymal stromal cells: from stromal cells to stem cells and vice versa. Transplantation 87 (Suppl): S36-S42, 2009.
50. Phinney DG: Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy. J Cell Biochem 113: 2806-2812, 2012.